RHO gene therapy (Acucela/University of Manchester)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRHO gene therapy (Acucela/University of Manchester)
Drug Alias Namerhodopsin-based optogenetic gene therapy (Acucela/University of Manchester)
ClassificationBiologics
Mechanisms of ActionRHO gene transference
TargetsRhodopsin
Therapy Area/IndicationsRetinal DiseasesRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Manchester
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRetinal DiseasesRetinitis Pigmentosa

Other Information

ATC CodeN/A
Related LinksN/A